when will glp 1 prices go down Novo cuts GLP-1 70%, but semaglutide revenue could grow in 2026 Declining GLP-1 drug prices reveals
Description
Benefits: Supports overall health
A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to patients taking another diabetes medication, DPP-4 inhibitors
Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy
They're not the same medication
Two additional patients who developed hypoglycemia involved co-administration of insulin
